Gerard Coombs


Co-founded Regentys Corporation a regenerative medicine company developing an extracellular matrix hydrogel for the treatment of Inflammatory Bowel Diseases. At Regentys he directed the company's operational activities. He is a business professional with extensive background in C-level management experience at several life sciences companies. Mr. Coombs has utilized his skill set to successfully design and implement operational and strategic programs, secure financing transactions and mergers and acquisitions. His industry experience includes pharmaceuticals, medical devices, technology, healthcare, software as a service, and consumer products. He has been involved in the organization of several start-up technology companies in the life sciences industry and has conducted the initial public offering and private placement of securities for several companies. BAA/UM